TrialScience translational medicine2021

A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma.

Priya Kumthekar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.